Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Alliant Energy Corporation — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Alliant Energy Corporation trades at $67.7 (market cap $17.51B). The key difference: Alliant Energy Corporation is far larger — about 2.5× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Alliant Energy Corporation pays a 3.17% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Alliant Energy Corporation for 65 Days on average.
| IONS | LNT | |
|---|---|---|
Market Cap | $7.10B | $17.51B |
Volume | 2,027,457 | 2,397,331 |
Sector | Health | Utilities |
52-Week High | $86.50 | $78.03 |
52-Week Low | $42.38 | $63.21 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $6.66B | $29.60B |
Dividend Yield | — | 3.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LNT trades at $66.96, up 0.75% today, with a bullish technical signal despite mixed momentum indicators. The company shows strong fundamentals with Q2 2026 EPS beating expectations at $0.65 versus $0.579, and revenue growth to $4.36B in 2025. Recent news highlights a $1.4B partnership with CareTrust REIT and institutional buying interest.
Outlook remains positive with analyst consensus price target of $74.00 (10.5% upside) and no sell ratings. Key risks include rising debt levels (debt-to-asset ratio up to 48.48% in 2025) and execution of $13.4B capital expenditure plan. The stock offers defensive utility exposure with 23-year dividend growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
